/Investor DB

Qiming Venture Partners — 2024 Investments

11 investments dated 2024 · listed companies and verified rows first · show all

Akulakuakulaku.comin𝕏Aug 2024

Akulaku is a payment and digital banking solutions platform serving 33 million customers, offering payment processing, digital banking services, and free shop setup with dedicated traffic support.

B2B MarketplacesFintech

Gordon Hu(Founder)William Li(Founder)

Co-investorsArbor VenturesCapria VenturesDCM VenturesEight Roads VenturesICU VenturesInnoVen Capital+9 more

Ausperbioausperbio.cominSeries A · Jul 2024 · $37M

AusperBio is a Phase II clinical-stage biopharmaceutical company developing oligonucleotide (ASO) therapeutics, with a focus on curative treatments for hepatitis B (HBV).

BiotechHealthtech

Guofeng Cheng(Founder)in

Co-investorsRA Capital

Bytelumiobytelumio.comSeries A · Sep 2024 · $13M

Co-investorsVertex Ventures China

Candid Therapeuticscandidrx.cominAug 2024

CandidRx develops T-cell engager antibodies to treat autoimmune diseases by redirecting T-cells to eliminate autoreactive B-cells.

BiotechHealthtechSan Diego, US

Ken Song(Chairman, President and CEO)inKenneth Song, M.D.(Executive Officer, Director)Arvind Kush(Executive Officer)Timothy Lu, M.D.(Executive Officer)inBernie Huyghe, Ph.D.(Executive Officer)

BoardJeffrey Tong, Ph.D.(Director)

Co-investorsForesite CapitalForesite LabsLifeSci Venture PartnersOrbiMedSamsara BioCapitalTCG Crossover+3 more

Stepfunstepfun.comSeries B · Dec 2024 · $3M

Daxin Jiang(Founder)inJiang Daxin(Founder)

Co-investorsHongShan Capital Group

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Dearer MedicalMufan PowerOriginal PointSONOSILICONTianhu TechnologyVignette Bio

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.